ID: ALA4571909

Max Phase: Preclinical

Molecular Formula: C38H54N6O7

Molecular Weight: 706.89

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(NC(=O)NC2CCN(C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]3(C)CO3)CC2)cc1

Standard InChI:  InChI=1S/C38H54N6O7/c1-24(2)20-30(33(45)38(5)23-51-38)41-35(47)32(22-26-10-8-7-9-11-26)42-34(46)31(21-25(3)4)43-37(49)44-18-16-28(17-19-44)40-36(48)39-27-12-14-29(50-6)15-13-27/h7-15,24-25,28,30-32H,16-23H2,1-6H3,(H,41,47)(H,42,46)(H,43,49)(H2,39,40,48)/t30-,31-,32-,38+/m0/s1

Standard InChI Key:  UKROSCGCJYOMQQ-FMMOARAPSA-N

Associated Targets(Human)

20S proteasome 530 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 706.89Molecular Weight (Monoisotopic): 706.4054AlogP: 4.02#Rotatable Bonds: 16
Polar Surface Area: 170.50Molecular Species: NEUTRALHBA: 7HBD: 5
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.36CX Basic pKa: CX LogP: 3.85CX LogD: 3.85
Aromatic Rings: 2Heavy Atoms: 51QED Weighted: 0.16Np Likeness Score: -0.50

References

1. Dong XW, Zhang JK, Xu L, Che JX, Cheng G, Hu XB, Sheng L, Gao AH, Li J, Liu T, Hu YZ, Zhou YB..  (2019)  Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles.,  164  [PMID:30639896] [10.1016/j.ejmech.2018.12.064]

Source